Arbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/Share

Arbutus Biopharma (NASDAQ: ABUS) reported Q1 EPS of ($0.36), versus ($0.34) reported last year. Revenue for the quarter came in at $1.4 thousand, versus $200 million reported last year.

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
• Espey Manufacturing (ESP) Tops Q4 EPS by 24c